Cargando…
Different COVID-19 outcomes among systemic rheumatic diseases: a nation-wide cohort study
OBJECTIVES: To investigate coronavirus disease 2019 (COVID-19)-associated risk of hospitalization and death in RA, AS, PsA, SLE and SSc in comparison with the general population during the first year of the pandemic, and compare their overall mortality with 2019. METHODS: Interlinking nationwide ele...
Autores principales: | Bournia, Vasiliki-Kalliopi, Fragoulis, George E, Mitrou, Panagiota, Mathioudakis, Konstantinos, Tsolakidis, Anastasios, Konstantonis, George, Tseti, Ioulia, Vourli, Georgia, Tektonidou, Maria G, Paraskevis, Dimitrios, Sfikakis, Petros P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384656/ https://www.ncbi.nlm.nih.gov/pubmed/35920774 http://dx.doi.org/10.1093/rheumatology/keac422 |
Ejemplares similares
-
All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015–2019
por: Bournia, Vasiliki-Kalliopi, et al.
Publicado: (2021) -
Introduction and switching of biologic agents are associated with antidepressant and anxiolytic medication use: data on 42 815 real-world patients with inflammatory rheumatic disease
por: Bournia, Vasiliki-Kalliopi, et al.
Publicado: (2020) -
Different systemic rheumatic diseases as risk factors for COVID-19-related mortality
por: Fragoulis, George E., et al.
Publicado: (2022) -
Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study
por: Fragoulis, George E., et al.
Publicado: (2021) -
Nocebo-Prone Behaviour in Patients with Autoimmune Rheumatic Diseases during the COVID-19 Pandemic
por: Fragoulis, George E., et al.
Publicado: (2020)